These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 12046635

  • 21. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J.
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [Abstract] [Full Text] [Related]

  • 22. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM, Alvariño F, Monti D.
    Sleep; 2000 Dec 15; 23(8):1075-84. PubMed ID: 11145322
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients.
    Mendels J.
    J Clin Psychiatry; 1994 Feb 15; 55(2):60-5. PubMed ID: 7915708
    [Abstract] [Full Text] [Related]

  • 24. Stimulus-control: nonpharmacologic treatment for insomnia.
    Baillargeon L, Demers M, Ladouceur R.
    Can Fam Physician; 1998 Jan 15; 44():73-9. PubMed ID: 9481465
    [Abstract] [Full Text] [Related]

  • 25. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.
    Pharmacopsychiatry; 2008 May 15; 41(3):106-14. PubMed ID: 18484552
    [Abstract] [Full Text] [Related]

  • 26. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 15; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 27. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 15; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]

  • 28. Trazodone improves the results of cognitive behaviour therapy of primary insomnia in non-depressed patients.
    Zavesicka L, Brunovsky M, Horacek J, Matousek M, Sos P, Krajca V, Höschl C.
    Neuro Endocrinol Lett; 2008 Dec 15; 29(6):895-901. PubMed ID: 19112384
    [Abstract] [Full Text] [Related]

  • 29. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
    Staner L, Eriksson M, Cornette F, Santoro F, Muscat N, Luthinger R, Roth T.
    Sleep Med; 2009 Jun 15; 10(6):616-20. PubMed ID: 18996742
    [Abstract] [Full Text] [Related]

  • 30. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
    Staner L, Danjou P, Luthringer R.
    Expert Rev Neurother; 2012 Feb 15; 12(2):141-53. PubMed ID: 22288669
    [Abstract] [Full Text] [Related]

  • 31. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
    Hoehns JD, Perry PJ.
    Clin Pharm; 1993 Nov 15; 12(11):814-28. PubMed ID: 8275648
    [Abstract] [Full Text] [Related]

  • 32. [Chronic sleep problems--possible to treat?].
    Bjorvatn B.
    Tidsskr Nor Laegeforen; 2000 Feb 20; 120(5):579-82. PubMed ID: 10833917
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study.
    Ziegler G, Ploch M, Miettinen-Baumann A, Collet W.
    Eur J Med Res; 2002 Nov 25; 7(11):480-6. PubMed ID: 12568976
    [Abstract] [Full Text] [Related]

  • 34. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV, Erman M, Krystal AD, Rosenberg R, Scharf M, Zammit GK, Wessel T.
    Curr Med Res Opin; 2006 Sep 25; 22(9):1633-42. PubMed ID: 16968566
    [Abstract] [Full Text] [Related]

  • 35. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
    Lasch K, Joish VN, Zhu Y, Rosa K, Qiu C, Crawford B.
    Curr Med Res Opin; 2009 Jul 25; 25(7):1699-710. PubMed ID: 19505198
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people.
    Cotroneo A, Gareri P, Nicoletti N, Lacava R, Grassone D, Maina E, De Sarro G, Cabodi S.
    Arch Gerontol Geriatr; 2007 Jul 25; 44 Suppl 1():121-4. PubMed ID: 17317444
    [Abstract] [Full Text] [Related]

  • 37. Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial.
    Watanabe N, Furukawa TA, Shimodera S, Morokuma I, Katsuki F, Fujita H, Sasaki M, Kawamura C, Perlis ML.
    J Clin Psychiatry; 2011 Dec 25; 72(12):1651-8. PubMed ID: 21457679
    [Abstract] [Full Text] [Related]

  • 38. Hypnotic dependence: zolpidem and zopiclone too.
    Prescrire Int; 2001 Feb 25; 10(51):15. PubMed ID: 11503851
    [Abstract] [Full Text] [Related]

  • 39. Discontinuation of hypnotics during cognitive behavioural therapy for insomnia.
    Zavesicka L, Brunovsky M, Matousek M, Sos P.
    BMC Psychiatry; 2008 Sep 18; 8():80. PubMed ID: 18801160
    [Abstract] [Full Text] [Related]

  • 40. The partial positive allosteric GABA(A) receptor modulator EVT 201 is efficacious and safe in the treatment of adult primary insomnia patients.
    Walsh JK, Thacker S, Knowles LJ, Tasker T, Hunneyball IM.
    Sleep Med; 2009 Sep 18; 10(8):859-64. PubMed ID: 19345644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.